Sun Pharmaceuticals Industries Ltd Quarterly Results

Gross Sales

12,815.58

13,436.94

13,264.22

12,524.51

11,813.33

Excise Duty

0

0

0

0

0

Net Sales

12,815.58

13,436.94

13,264.22

12,524.51

11,813.33

Other Operating Income

143.26

238.52

27.17

128.24

169.57

Other Income

612.87

465.62

354

532.55

605.94

Total Income

13,571.71

14,141.08

13,645.39

13,185.3

12,588.84

Total Expenditure

9,604.43

9,982.61

9,352.43

9,045.13

9,049.39

PBIDT

3,967.28

4,158.47

4,292.96

4,140.17

3,539.45

Interest

49.14

51.51

69.17

61.54

73.57

PBDT

3,918.14

4,106.96

4,223.79

4,078.63

3,465.88

Depreciation

663.79

630.56

625.91

655.13

650.36

Minority Interest Before NP

0

0

0

0

0

Tax

1,093.71

558.86

567.21

552.25

148.93

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

2,160.64

2,917.54

3,030.67

2,871.25

2,666.59

Minority Interest After NP

4.05

9.6

-2.83

24.89

4.16

Net Profit after Minority Interest

2,149.88

2,903.38

3,040.16

2,835.62

2,654.58

Extra-ordinary Items

-240.13

-265.34

0

0

-96.26

Adjusted Profit After Extra-ordinary item

2,390.01

3,168.72

3,040.16

2,835.62

2,750.84

EPS (Unit Curr.)

9

12.1

12.7

11.8

11.1

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

1,050

0

0

0

Equity

239.93

239.93

239.93

239.93

239.93

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

30.95

30.94

32.36

33.05

29.96

PBDTM(%)

30.57

30.56

31.84

32.56

29.33

PATM(%)

16.85

21.71

22.84

22.92

22.57